Related Experiment Video
Updated: Apr 12, 2026

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
Published on: March 21, 2025
Multiparametric Magnetic Resonance Imaging in Prostate Cancer Management: Current Status and Future Perspectives
Tom W J Scheenen1, Andrew B Rosenkrantz, Masoom A Haider
1From the *Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands; †Department of Radiology, NYU Langone Medical Center, New York, NY; and ‡Department of Medical Imaging, Sunnybrook Health Sciences Centre; and University of Toronto, Toronto, Canada.
Abstract:
This article reviews recent and ongoing developments in multiparametric magnetic resonance imaging (mpMRI) of the prostate. Advances in T2-weighted imaging, diffusion-weighted imaging, dynamic contrast-enhanced imaging, and spectroscopic imaging are described along with advances related to radiofrequency coils and imaging at high magnetic field. As mpMRI is increasingly becoming routine in various aspects of clinical prostate cancer management, its role in detection, localization, staging, assessment of aggressiveness, and active surveillance is discussed. Combined with growing clinical adoption of the techniques already at hand, continual optimization of acquisition techniques and image interpretation schemes will further strengthen the role of mpMRI as an important diagnostic test in prostate cancer management.
Related Concept Videos
Imaging Studies IV: Magnetic Resonance Imaging
Magnetic Resonance Imaging

